
CJC-1295 No DAC
Short-acting modified GHRH analog (mod GRF 1-29) for pulsatile-release research.
Sold as 1 lyophilized vial.
Price for 1 lyophilized vial · $3.50 / mg
CJC-1295 without DAC, also known as modified GRF (1-29), is a short-acting growth-hormone-releasing hormone analog. Its brief half-life makes it a common choice in research designs that aim to mimic natural pulsatile growth-hormone release.
Ingredients
CJC-1295 no DAC (≥98% purity by HPLC). 10 mg lyophilized peptide per vial. No non-active ingredients.
Directions
For research use only. Reconstitute per your study protocol and use within 30 days. Store lyophilized at 2–8°C away from light.
Warnings
NOT FOR HUMAN OR ANIMAL CONSUMPTION. Laboratory research use only. Not approved for human use. Not intended to diagnose, treat, cure, or prevent any disease.
Shipping Information
- • Dispatched within 24 hours on business days
- • Discreet, temperature-aware packaging
- • Tracking provided on every shipment
- • Free shipping to Canada and the US on orders over $150
- • Members: free Canada/US shipping from $75
- • Otherwise $12 Canada, $25 US. International is $40
Specifications
Customer Reviews
We have ordered several times and the quality has been consistent every time.
Reliable supplier, strong reconstitution characteristics, no residue.
Great for our continuing research protocols. Matches what we expected.
Arrived fast and well packaged. Lyophilization looked clean with a stable cake.
Excellent quality and consistent results across multiple batches.
Satisfied with the product and how it was packaged.
Clean reconstitution and consistent quality. Would order again.
Related Products

Ipamorelin / CJC-1295
1 vial · 10 mg – 20 mg
Synergistic growth-hormone secretagogue blend studied for vitality and recovery.

Ipamorelin
1 vial · 10 mg
Selective pentapeptide growth-hormone secretagogue, supplied on its own.

IGF-1 LR3
1 vial · 1 mg
Long-arginine IGF-1 analog studied for cell growth and differentiation pathways.
